Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.

S D Beck1, R S Foster, R Bihrle

  • 1Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

The Journal of Urology
|May 9, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Urologic oncology·2018
Same author

Detection and isolation of Toxoplasma gondii from fresh semen of naturally infected dogs in Southern Brazil.

Reproduction in domestic animals = Zuchthygiene·2016
Same author

Differentiation of prostate cancer from normal tissue in radical prostatectomy specimens by desorption electrospray ionization and touch spray ionization mass spectrometry.

The Analyst·2014
Same author

Association of antibodies against Neospora caninum in mares with reproductive problems and presence of seropositive dogs as a risk factor.

Veterinary parasitology·2014
Same author

Distal urethrectomy for localized penile squamous carcinoma in situ extending into the urethra: an updated series.

International urology and nephrology·2014
Same author

The metabolic complications of urinary diversion.

Urologic oncology·2011
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Aortic resection during retroperitoneal lymph node dissection for metastatic germ cell cancer is justified. This procedure offers therapeutic benefit with acceptable morbidity, even in complex cases.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Genitourinary Cancer

Background:

  • Metastatic germ cell cancer often requires extensive treatment.
  • Post-chemotherapy retroperitoneal lymph node dissection (RPLND) is a critical component of management.
  • Aortic involvement necessitates complex surgical considerations during RPLND.

Purpose of the Study:

  • To evaluate the morbidity and therapeutic benefit of aortic resection and replacement during RPLND in patients with metastatic germ cell cancer.
  • To assess outcomes in patients undergoing this extensive surgical procedure.

Main Methods:

  • Retrospective review of 15 patients who underwent aortic resection and replacement during RPLND between 1970 and 1998.
  • Analysis of additional procedures performed concurrently and pathological findings.

Related Experiment Videos

Main Results:

  • 15 patients underwent aortic replacement, with 11 requiring additional major resections (e.g., nephrectomy, vena caval resection).
  • Viable tumor was present in 80% of specimens; teratoma in 20%.
  • 33% of all patients achieved no evidence of disease; 100% of those treated with induction chemotherapy alone had no evidence of disease. No graft-related complications occurred.

Conclusions:

  • Aortic resection during RPLND for metastatic germ cell cancer is a justifiable procedure.
  • The therapeutic benefits outweigh the associated morbidity.
  • Careful patient selection and surgical expertise are crucial for successful outcomes.